You just read:

Intarcia Announces FDA Filing Acceptance of New Drug Application (NDA) for ITCA 650 for the Treatment of Type 2 Diabetes

News provided by

Intarcia Therapeutics, Inc.

Feb 03, 2017, 17:41 ET